MICHAEL THOMAS ADLER M.D.
Prescription History 1639408933
Obstetrics & Gynecology in Houston, TX
Quality Rating: 77 out of 100 score
NPI Status: Active since December 15, 2009
Contact Information
6410 FANNIN
SUITE 250
HOUSTON, TX
ZIP 77030
Phone: (832) 325-7131
Fax: (713) 512-2216
Prescription History for Informed Healthcare Decisions
When choosing a healthcare provider, especially one who prescribes medications, having access to their prescribing history can be invaluable. This page offers detailed insights into the prescriptions MICHAEL THOMAS ADLER M.D. has written for Medicare beneficiaries in the past, empowering both current and prospective patients to make informed decisions about their healthcare.
Why This Information Matters
This Medicare Part D dataset provides transparency into the provider’s prescribing patterns, helping you understand the scope and nature of their pharmaceutical care. Here’s what you can learn:
- Prescribing Trends: See which medications—both generic and brand-name—this provider has most frequently prescribed.
- Specialization Insights: The types of drugs prescribed can give insight into the provider’s areas of focus or specialization, whether it’s managing chronic conditions, addressing acute illnesses, or providing preventive care.
- Cost Awareness: Learn about the total drug costs associated with these prescriptions, which may help you anticipate your own costs and coverage needs.
- Patient-Centered Decision Making: Understanding a provider’s prescribing practices helps you align their expertise with your health goals, ensuring the care you receive is consistent with your expectations.
- Generic Name
- Estrogens, Conjugated
- Specialty
- Obstetrics & Gynecology
- Times Prescribed
- 15
- Number of 30-Day Refills Prescribed
- 31.1
- What is this prescription?
- A pharmaceutical preparation containing a mixture of water-soluble, conjugated estrogens derived wholly or in part from URINE of pregnant mares or synthetically from ESTRONE and EQUILIN. It contains a sodium-salt mixture of estrone sulfate (52-62%) and equilin sulfate (22-30%) with a total of the two between 80-88%. Other concomitant conjugates include 17-alpha-dihydroequilin, 17-alpha-estradiol, and 17-beta-dihydroequilin. The potency of the preparation is expressed in terms of an equivalent quantity of sodium estrone sulfate.
- What is this prescription used for?
- This medication is a female hormone. It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. Certain estrogen products may also be used by men and women to treat cancers (certain types of prostate cancer, breast cancer that has spread to other parts of the body) and by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure).
- Generic Name
- Estrogen,con/M-Progest Acet
- Specialty
- Obstetrics & Gynecology
- Times Prescribed
- 13
- Number of 30-Day Refills Prescribed
- 13
- What is this prescription used for?
- This medication contains 2 female hormones: an estrogen (such as conjugated estrogen, estradiol) and a progestin (such as medroxyprogesterone, norethindrone, norgestimate). Some brands of this medication may contain progesterone instead of a progestin. Progesterone and progestin both act like the form of the natural hormone (progesterone) produced by your body. This medication is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. The progestin or progesterone in this medication helps to reduce the risk of cancer of the uterus which can be caused by using estrogen. Women who have had their uterus removed do not need the progestin or progesterone. They should not use this combination medication. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen/progestin treatment.
This dataset provides information about prescriptions written for Medicare beneficiaries in the year 2022. It does not include prescriptions for patients with private insurance, Medicaid, or other coverage types. However, this information remains valuable for all patients, as it may reflect the provider's overall prescribing preferences and approach to pharmaceutical care. This can help you make better-informed decisions when considering or continuing care with this provider.